eIF4E is persistently hyperactivated due to genetic alterations of pathway components located upstream of the 4EBP1/eIF4E axis, as the genes encoding 4EBP1 and eIF4E remain normal in the vast majority of cancers, including RCC [5, 7, 8]. The gene discussed is EIF4E; the disease is cancer.